Risatti; Christina Ann

Patent Applications and Registrations

Patent applications and USPTO patent grants for Risatti; Christina Ann.The latest application filed is for "methods for the preparation of hiv attachment inhibitor piperazine prodrug compound".

Company Profile

0.8.10

Risatti; Christina Ann - Clarksburg NJ
Risatti; Christina Ann - Princeton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and intermediates for the preparation of (4bS,5aR)-12-cyclohexyl-N-(N,N-dimethylsulfamoyl)-3-methoxy-5a-((1R,5S)-3- -methyl-3,8-diazabicyclo [3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-A]indole-9-carboxamide Grant 9,556,204 - DelMonte , et al. January 31, 2	2017-01-31
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,403,821 - Eastgate , et al. August 2, 2	2016-08-02
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,394,322 - Eastgate , et al. July 19, 2	2016-07-19
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,376,458 - Eastgate , et al. June 28, 2	2016-06-28
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20160152644 - Eastgate; Martin D. ; et al.	2016-06-02
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20160108029 - Eastgate; Martin D. ; et al.	2016-04-21
Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,255,113 - Eastgate , et al. February 9, 2	2016-02-09
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,249,168 - Eastgate , et al. February 2, 2	2016-02-02
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,243,010 - Eastgate , et al. January 26, 2	2016-01-26
NOVEL METHODS AND INTERMEDIATES FOR THE PREPARATION OF (4bS,5aR)-12-CYCLOHEXYL-N-(N,N-DIMETHYLSULFAMOYL)-3-METHOXY-5a-((1R,5S)-3- -METHYL-3,8-DIAZABICYCLO[3.2.1]OCTANE-8-CARBONYL)-4b,5,5a,6-TETRAHYDROBENZ- O [3,4]CYCLOPROPA[5,6]AZEPINO[1,2-A]INDOLE-9-CARBOXAMIDE App 20150133654 - DelMonte; Albert J. ; et al.	2015-05-14
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038709 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038717 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038711 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038716 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038712 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038710 - Eastgate; Martin D. ; et al.	2015-02-05
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 8,889,869 - Eastgate , et al. November 18, 2	2014-11-18
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20130203992 - Eastgate; Martin D. ; et al.	2013-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.